CLSA Infrastructure Report
CLSA Infrastructure Report
Sector outlook
Bharat Parekh
Covid-19 curfew cuts
Stocks pricing in lot more pessimism—NIP is the key stimulus
[email protected]
+91 22 6650 5020 After factoring-in the crude crash impact (Covid-19 hits regulated utilities) we see the
Covid-19-led 42-day country-wide lock-down, lower utilisation rates from demand
destruction and weak government finances which were diverted to social causes and
claims slowing domestic Capex. More importantly, these disruptions are happening
during the peak ordering (4Q) and execution season of 1H. Hence, we cut our E&C
universe target prices by 8%-27% with EPS cuts of 3%-37% as we factor-in complete
site shutdowns from 23 March to 7 May, particularly due to an exodus of workers. We
take a deep dive into leverage and pledges, to find it is an issue in our universe. Also,
FY21 will be year of litigation due to force majeure, so we research anecdotal
15 April 2020 evidence. Last, the government has little choice but to pump-prime the economy with
its own/CPSE Capex, as the corporate tax cut failed to revive Capex. We advises
India buying early-cycle plays trading, which happened to be at 10-year multiple lows such
Infrastructure as L&T, JKIL, IRB, Sadbhav & NCC following sharp 15%-45% price corrections.
We would like to thank Evalueserve for its help in preparing our research reports. Bhavik Mehta (IT); Kushal Shah (Midcaps); Shreya Shivani (BFSI) and Akshay
Chandak (Strategy) provide research support services to CLSA.
India announced ’Janta Prime Minister called for a curfew and lockdown
(people's) curfew’ on March
19 on 22 March followed by
a nationwide lockdown
from 25 March to 14 April
Source: PIB
Figure 2
50%
This was missing for most
companies, except L&T, 40%
which won a few large
orders 30%
20%
10%
0%
FY17 FY18 FY19 FY20
Source: Company, CLSA
Figure 3
Find CLSA research on Bloomberg, Thomson Reuters, Factset and CapitalIQ - and profit from our evalu@tor proprietary database at clsa.com
Figure 4
Source: CLSA
Figure 5
Source: CLSA, World Health Organisation, Ministry of Health, Worldometer. As on Noon, 14-Apr-20
Figure 6
The exodus of workers from Covid-19: exodus of workers from metro areas
metro areas following the
curfew will hurt execution
even if lock-down is lifted
as planned.
Source: CLSA
Figure 7
Many state governments The government of Maharashtra: orders to resume work on large projects
such as Maharashtra have
issued orders to start work
on large infrastructure
projects such as the
Mumbai-Nagpur
expressway. . .
Figure 8
L&T committed to donate Larsen & Toubro: its fight against Covid-19
Rs1.5bn to the PM CARES
Fund to fight Covid-19
Source: Company
Figure 9
Figure 10
BHEL ran run only essential BHEL: Business disruptions due to Covid-19
services in its
manufacturing facilities
from 23-03-2020 until 31-
03-2020
Source: BSE
Figure 11
Source: BSE
Figure 12
Source: Company
Figure 13
Mumbai Metro Line 4 Work Mumbai Metro Line 4: during the lock-down
stopped due to COVID-19
Source: CLSA
Figure 14
Source: CLSA
Figure 15
Source: CLSA
Figure 16
Figure 17
Figure 18
Source: CLSA
Figure 19
Figure 20
32%
63%
Figure 21
Figure 23
Figure 24
IRB’s recently-won Mumbai Mumbai-Pune expressway: closed during the Covid-19 lockdown
Pune expressway tolling is
also shut
Source: MSRDC
Figure 25
Figure 26
The compensation due to NHAI: what will the NHAI reimburse to concessionaire be?
force majeure includes
interest payments on debts
and O&M expenses and not
loss of revenue or any debt
repayment
Source: PIB
Figure 28
Source: Company
Figure 29
Source: Company
Figure 30
Source: Company
Figure 31
Source: Company
Figure 32
Krishnagiri Thopur had
realised 90% of its interest L&T IDPL Road SPVs: Impact of demonetization on Krishnagiri Thopur
cost by end-FY17
Source: Company
Figure 33
Krishnagiri Walajahpet had L&T IDPL Road SPVs: Impact of demonetization on Krishnagiri Walajahpet
realized 90% of its interest
cost by end-FY17
Source: Company
Figure 34
Source: Company
What’s different in the India E&C and developer leverage: net debt to equity
ensuing cycle is the under-
leveraged balance-sheets of
contractors and developers
alike
Source: CLSA
Figure 36
Figure 37
30%
28%
It has steadily increased its
shareholding 26%
24%
22%
20%
FY18 FY19 Jun-19 Sep-19 Dec-19 Current
Source: CLSA, Company
Figure 38
Figure 39
It pledged an additional
26% of its shares in 4Q
Disruptions in FY20
Extended monsoon (June – September 2019)
Extended monsoon affected q JKIL: June and July were very harsh but apart from that there was a big issue with
construction activities of labour shortage during Parliamentary elections
big players like JKIL, q Sadbhav Engg: 2 projects worth Rs. 21bn that is Lucknow Ring Road and Mumbai -
Sadbhav and NCC Nagpur where we already started the construction before monsoon, actually. And
during the monsoon period, the major construction activity could not be conducted in
these two projects mainly because both are the greenfield projects
q NCC: Nagpur – Mumbai E-way slipped due to heavy rainfall. R.S. Raju – Revenue hit
due to extended monsoon in 2QFY20 is Rs2.5-3bn
q Coal India: Coal India said its output for the six months to the end of September 2019
fell 6%, with September production dropping 23.5% to the lowest level in months
Natural Calamities
Floods and cyclones caused q Karnataka Floods (Aug 2019): Overall, the property damage caused by the floods
huge damage to plant and across the state is estimated to be around ₹35,160.81 crore.
property last year q Cyclone Fani (May 2019):The overall damage caused by Fani in India and Bangladesh
combined is estimated to be around ₹58 thousand crores (US$8.1 billion)
q Dipka Mine Flooding (Oct 2019): The flooding at the Dipka mine, which produces
more than 30 million tonnes a year of thermal coal and accounts for some 5% of Coal
India's overall output including to NTPC Ltd's Sipat plant. An NTPC official said the
company's plant in Sipat, which had no stock of coal as of Sept. 30, according to
government data, was trying to arrange alternate sources of coal.
Figure 41
Figure 42
UP has the most building Top five states with highest number of building and other construction workers
and construction workers
Figure 44
Source: CLSA
Figure 46
Some of JKIL’s bids were JKIL (JKIP.BO) – BUY (CMP – Rs80, target price Rs230)
postponed due to covid-19 q JKIL is the least impacted due to its well-funded clients such as JICA-funded, Mumbai
which may impact its EPS Metro Rail corp. and lofty book but it's execution may be impacted by lock-down in
by 8%-21% in FY20-21 Maharashtra (most impacted state by Covid19) and labour exodus. Here company has
done a good job by keeping as many workers as possible in labour camps (Figure 47)
and keep them in good spirits.
q Owing to Covid-19 Pandemic, some of its bids has been postponed. Due to which we
cut our order Inflow target for both FY20 and FY21 by 12% and 28% respectively.
q Moreover, the lock-down has also stalled execution for 9 days in March and almost a
month in Q1FY21 impacting the revenue of the company both in Q4FY20 and Q1FY21
q This would impact the EPS of the company by 8% and 21% respectively in FY20-21.
q JKIL is an inexpensive play (3x FY20CL) on high-growth urbanisation Capex with its
success in metro rail contracting.
Figure 47
JKIL has done a great job of JKIL: managers addressing workers during the lock-down
retaining workers in its
labour camp
Source: CLSA
Figure 48
Source: CLSA
Figure 49
Stalled execution due to Sadbhav Engineering (SADE.BO) – BUY (CMP – Rs 26, target price Rs130)
lockdown may impact EPS q Owing to Covid-19 Pandemic, many of Sadbhav’s bids has been postponed by NHAI.
of the company by 18-34% This coupled with managements pre-occupation with concluding it's strategic deal with
in FY20-21CL CPPIB-led InvIT, led to Sadbhav not wining any order during FY20. Due to which we
cut our order Inflow target for both FY20 to nil and FY21 by 18%.
q Moreover, the lock-down has also stalled execution for 9 days in March and almost a
month in Q1FY21 impacting the revenue of the company both in Q4FY20 and Q1FY21
q This would impact the EPS of the company by 18% and 37% during FY20 -21CL.
q That said Sadbhav has almost halved its group debt (Figure 51) on conclusion of its
landmark strategic deal with CPPIB-led InvIT (Figure 50).
q Also promoters have been bringing down their stock pledge by deleraging balance
sheet and replacing shares with land till 3QFY20 (Figure 39). However pledge has gone
up in 4Q due to fall in stock but we see enough cover with promoters.
Sadbhav concluded the
q The Sadbhav Infra (SIPL, a 69% subsidiary and 42% of SOTP) transformative InvIT deal
largest highway asset sale
shall open a window to future asset monetisation and making its EPC business, which
to the CPPIB-led private
trades at a PE of 1.3x FY20 ex-SIPL market value (Figure 60), asset-light.
InvIT
Figure 50
Source: CLSA
Figure 51
Figure 52
Stalled execution for EPC IRB Infra (IRBI.BO) – BUY CMP – Rs 66, target price Rs166
projects brings our EPS q IRB has timely deleveraged its balance sheet during 4QFY20 (Figure 54) with its
down by 4%-7% for FY20- landmark 51:49 private InvIT deal (Figure 53) with Government of Singapore (GIC).
21CL This deal shall also open window of future project injection into the InvIT making its
business model scalable and sustainable.
q Owing to Covid-19 Pandemic, some key bids at NHAI has been postponed.
q Moreover, the lock-down has also stalled execution of EPC projects for 9 days in
March and likely almost a month in Q1FY21 impacting the revenue of the company
both in Q4FY20 and Q1FY21. We expect company to receive force majeure claims for
the lock-down during FY21, restricting EPS hit.
q IRB has taken only a partial moratorium in March 2020 interest and expects to take the
same in April as well, if toll-ban continues beyond April 14th.
q Slowdown in EPC execution and loss of profit in toll business would impact the EPS of
the company by 7% and 11% during FY20 -21CL.
GIC invested Rs44bn / q Key to track for IRB is that when does NHAI and Maharashtra state allow tolling and
US$621bn in a private InvIT start of toll-ways concession by NHAI.
with IRB to take out debt of q The stock trades at a compelling valuation, at a 60% discount to our SoTP, a 5x
Indian banks and reduce FY20CL PE
IRB’s equity commitment
Figure 53
Source: CLSA
Figure 54
Leverage is expected to fall IRB Infra: pre and post InviT leverage
63% post IRB-GIC InviT
Source: CLSA
Figure 55
Figure 56
37
32
27 +1sd 26.70x
22
avg 20.17x
17
-1sd13.65x
12
L&T’s E&C PE has fallen
below -1 std. of its long 7
time average. It is still
above its low of 9x during
the global financial crisis of
2008 Source: CLSA, Company
Figure 57
Source: CLSA
Figure 58
10.0
avg 8.83x
8.0
6.0
-1sd 4.93x
4.0
2.0
Apr 17 Oct 17 Apr 18 Oct 18 Apr 19 Oct 19 Apr 20
Source: CLSA
Figure 59
10.0
-1sd 8.7x
8.0
6.0
4.0
2.0
Apr 17 Oct 17 Apr 18 Oct 18 Apr 19 Oct 19 Apr 20
Source: CLSA
Figure 60
0.0
Apr 17 Oct 17 Apr 18 Oct 18 Apr 19 Oct 19 Apr 20
Source: CLSA
Figure 61
Source: CLSA
Figure 62
Figure 63
Figure 64
Figure 65
Figure 66
Figure 67
Annexure: NIP
Figure 68
10
The annual phasing shown
in the chart does not
8
include projects worth
Rs12.6tn, awaiting details
from states like Gujarat and 5
the incorporation of Power FY20 (est.) FY21 (P) FY22 (P) FY23 (P) FY24 (P) FY25 (P)
CPSE Capex Source: CLSA
Figure 69
The NIP aims to take the NIP Capex vs previous five year plan
Capex cycle into a higher 25
Rs tn Centre State Private Total
orbit to address the
infrastructure deficit, 19.5 19.0
improve the quality of life 20
of citizens and businesses 4.2 4.0
and India’s ranking globally 13.6 13.8
15 12.8
11.1
10.2 10.0 2.6 7.4 6.7 3.6
8.5 9.2 3.9
10
6.3 7.0 2.5 2.5 4.1
2.6 5.5 4.1
5.3 3 3.7
2 2.3 3.8 3.7 3.1
5 1.5 4.3
3.5 7.9 8.3
2.4 2.7 3 5.5 6.1 5.2
3.9 3.8 3.9
1.4 1.6 1.7 2 2.3
0
FY13 FY14 FY15 FY16 FY17 FY18E FY19E FY20E FY21P FY22P FY23P FY24P FY25P
Source: CLSA
Figure 70
Source: CLSA
Figure 71
Source: CLSA
Figure 72
Source: CLSA
Figure 73
. . . consisting of EPC
contractors, steel, cement,
transport and banks
Source: CLSA
Figure 74
Figure 76
Figure 77
Research subscriptions
To change your report distribution requirements, please contact your CLSA sales representative or email us at [email protected].
You can also fine-tune your Research Alert email preferences at https://www.clsa.com/member/tools/email_alert/.
Companies mentioned
Ashoka Buildcon (N-R)
AT S Infratech (N-R)
Bharat Heavy Elec (BHEL IB - RS22.1 - BUY)
Coal India (COAL IS - RS145.9 - BUY)
CPPIB (N-R)
Dilip Buildcon (N-R)
GIC Private Limited (N-R)
Hindustan Construction (N-R)
IRB Infra (IRB IB - RS65.9 - BUY)
J Kumar Infra (JKIL IN - RS79.8 - BUY)
Krishnagiri Thopur (N-R)
Krishnagiri Walajahpet (N-R)
L&T Finance (N-R)
L&T IDPL (N-R)
L&T infotech (N-R)
L&T metro (N-R)
L&T power development (N-R)
L&T Realty (N-R)
L&T Tech (LTTS IS - RS1,155.8 - BUY)
Larsen & Toubro (LT IB - RS865.7 - BUY)
MindTree (N-R)
MMRDA (N-R)
Nagarjuna (NJCC IN - RS23.9 - BUY)
NTPC (NTPC IS - RS88.7 - BUY)
Sadbhav (SADE IN - RS26.4 - BUY)
Schindler (N-R)
Thermax (N-R)
Analyst certification
The analyst(s) of this report hereby certify that the views expressed in this research report accurately reflect my/our
own personal views about the securities and/or the issuers and that no part of my/our compensation was, is, or will
be directly or indirectly related to the specific recommendation or views contained in this research report.
Important disclosures
Recommendation history of IRB Infrastructure Developers Ltd IRB IB
The policy of CLSA and CL Securities Taiwan Co., Ltd. (“CLST”) is to conjunction with the research disclaimer as set out at
only publish research that is impartial, independent, clear, fair, and not www.clsa.com/disclaimer.html and the applicable regulation of the
misleading. Regulations or market practice of some concerned market where the analyst is stationed and hence subject
jurisdictions/markets prescribe certain disclosures to be made for to. Investors are strongly encouraged to review this disclaimer before
certain actual, potential or perceived conflicts of interests relating to investing.
a research report as below. This research disclosure should be read in Neither analysts nor their household members/associates/may
have a financial interest in, or be an officer, director or advisory board Place, 88 Queensway, Hong Kong and/or; (c) CLST Compliance (27/F,
member of companies covered by the analyst unless disclosed herein. 95, Section 2 Dun Hua South Road, Taipei 10682, Taiwan, telephone
In circumstances where an analyst has a pre-existing holding in any (886) 2 2326 8188). EVA® is a registered trademark of Stern, Stewart
securities under coverage, those holdings are grandfathered and the & Co. "CL" in charts and tables stands for CLSA estimates, “CT” stands
analyst is prohibited from trading such securities. for CLST estimates, "CRR" stands for CRR Research estimates and
Unless specified otherwise, CLSA/CLST or its respective affiliates, “CS” for Citic Securities estimates unless otherwise noted in the
did not receive investment banking/non-investment banking income source.
from, and did not manage/co-manage a public offering for, the listed This publication/communication is subject to and incorporates
company during the past 12 months, and it does not expect to receive the terms and conditions of use set out on the www.clsa.com website
investment banking compensation from the listed company within the (https://www.clsa.com/disclaimer.html). Neither the
coming three months. Unless mentioned otherwise, CLSA/CLST does publication/communication nor any portion hereof may be reprinted,
not own 1% or more of any class of securities of the subject company, sold, resold, copied, reproduced, distributed, redistributed, published,
and does not make a market, in the securities. (For full disclosure of republished, displayed, posted or transmitted in any form or media or
interest for all companies mention on this report, please refer to by any means without the written consent of CLSA and/or CLST.
http://www.clsa.com/member/research_disclosures/ for details.) CLSA and/or CLST has/have produced this
The analysts included herein hereby confirm that they have not publication/communication for private circulation to professional,
been placed under any undue influence, intervention or pressure by institutional and/or wholesale clients only, and may not be distributed
any person/s in compiling this research report. In addition, the to retail investors. The information, opinions and estimates herein are
analysts attest that they were not in possession of any material, non- not directed at, or intended for distribution to or use by, any person
public information regarding the subject company at the time of or entity in any jurisdiction where doing so would be contrary to law
publication of the report. Save from the disclosure below (if any), the or regulation or which would subject CLSA, and/or CLST to any
analyst(s) is/are not aware of any material conflict of interest. additional registration or licensing requirement within such
As analyst(s) of this report, I/we hereby certify that the views jurisdiction. The information and statistical data herein have been
expressed in this research report accurately reflect my/our own obtained from sources we believe to be reliable. Such information has
personal views about the securities and/or the issuers and that no not been independently verified and we make no representation or
part of my/our compensation was, is, or will be directly or indirectly warranty as to its accuracy, completeness or correctness. Any
related to the specific recommendation or views contained in this opinions or estimates herein reflect the judgment of CLSA and/or
report or to any investment banking relationship with the subject CLST at the date of this publication/communication and are subject
company covered in this report (for the past one year) or otherwise to change at any time without notice. Where any part of the
any other relationship with such company which leads to receipt of information, opinions or estimates contained herein reflects the views
fees from the company except in ordinary course of business of the and opinions of a sales person or a non-analyst, such views and
company. The analyst/s also state/s and confirm/s that he/she/they opinions may not correspond to the published view of CLSA and/or
has/have not been placed under any undue influence, intervention or CLST. Any price target given in the report may be projected from one
pressure by any person/s in compiling this research report. In or more valuation models and hence any price target may be subject
addition, the analysts included herein attest that they were not in to the inherent risk of the selected model as well as other external
possession of any material, nonpublic information regarding the risk factors. Where the publication does not contain ratings, the
subject company at the time of publication of the report. The analysts material should not be construed as research but is offered as factual
further confirm that none of the information used in this report was commentary. It is not intended to, nor should it be used to form an
received from CLSA's Corporate Finance department or CLSA's Sales investment opinion about the non-rated companies.
and Trading business. Save from the disclosure below (if any), the This publication/communication is for information purposes only
analyst(s) is/are not aware of any material conflict of interest. and it does not constitute or contain, and should not be considered as
Key to CLSA/CLST investment rankings: BUY: Total stock return an offer or invitation to sell, or any solicitation or invitation of any
(including dividends) expected to exceed 20%; O-PF: Total expected offer to subscribe for or purchase any securities in any jurisdiction
return below 20% but exceeding market return; U-PF: Total expected and recipient of this publication/communication must make its own
return positive but below market return; SELL: Total return expected independent decisions regarding any securities or financial
to be negative. For relative performance, we benchmark the 12- instruments mentioned herein. This is not intended to provide
month total forecast return (including dividends) for the stock against professional, investment or any other type of advice or
the 12-month forecast return (including dividends) for the market on recommendation and does not take into account the particular
which the stock trades. investment objectives, financial situation or needs of individual
We define as “Double Baggers” stocks we expect to yield 100% recipients. Before acting on any information in this
or more (including dividends) within three years at the time the stocks publication/communication, you should consider whether it is
are introduced to our “Double Bagger” list. "High Conviction" Ideas suitable for your particular circumstances and, if appropriate, seek
are not necessarily stocks with the most upside/downside, but those professional advice, including tax advice. Investments involve risks,
where the Research Head/Strategist believes there is the highest and investors should exercise prudence and their own judgment in
likelihood of positive/negative returns. The list for each market is making their investment decisions. The value of any investment or
monitored weekly. income my go down as well as up, and investors may not get back the
Overall rating distribution for CLSA (exclude CLST) only Universe: full (or any) amount invested. Past performance is not necessarily a
Overall rating distribution: BUY / Outperform - CLSA: 72.63%, guide to future performance. CLSA and/or CLST do/does not accept
Underperform / SELL - CLSA: 27.28%, Restricted - CLSA: 0.36%; Data any responsibility and cannot be held liable for any person’s use of or
as of 31 Mar 2020. Investment banking clients as a % of rating reliance on the information and opinions contained herein. To the
category: BUY / Outperform - CLSA: 9.03%, Underperform / SELL - extent permitted by applicable securities laws and regulations, CLSA
CLSA: 2.80%; Restricted - CLSA: 0.18%. Data for 12-month period and/or CLST accept(s) no liability whatsoever for any direct or
ending 31 Mar 2020. consequential loss arising from the use of this
Overall rating distribution for CLST only Universe: Overall rating publication/communication or its contents.
distribution: BUY / Outperform - CLST: 71.43%, Underperform / SELL To maintain the independence and integrity of our research, our
- CLST: 28.57%, Restricted - CLST: 0.00%. Data as of 31 Mar 2020. Corporate Finance, Sales Trading, Asset Management and Research
Investment banking clients as a % of rating category: BUY / business lines are distinct from one another. This means that CLSA’s
Outperform - CLST: 0.00%, Underperform / SELL - CLST: 0.00%, Research department is not part of and does not report to CLSA
Restricted - CLST: 0.00%. Data for 12-month period ending 31 Mar Corporate Finance department or CLSA’s Sales and Trading business.
2020. Accordingly, neither the Corporate Finance nor the Sales and Trading
There are no numbers for Hold/Neutral as CLSA/CLST do not department supervises or controls the activities of CLSA’s research
have such investment rankings. For a history of the recommendation, analysts. CLSA’s research analysts report to the management of the
price targets and disclosure information for companies mentioned in Research department, who in turn report to CLSA’s senior
this report please write to: CLSA Group Compliance, 18/F, One Pacific management. CLSA has put in place a number of internal controls
designed to manage conflicts of interest that may arise as a result of Indonesia by PT CLSA Sekuritas Indonesia; in Japan by CLSA
CLSA engaging in Corporate Finance, Sales and Trading, Asset Securities Japan Co., Ltd.; in Korea by CLSA Securities Korea Ltd.; in
Management and Research activities. Some examples of these Malaysia by CLSA Securities Malaysia Sdn. Bhd.; in the Philippines by
controls include: the use of information barriers and other controls CLSA Philippines Inc (a member of Philippine Stock Exchange and
designed to ensure that confidential information is only shared on a Securities Investors Protection Fund); in Singapore by CLSA
“need to know” basis and in compliance with CLSA’s Chinese Wall Singapore Pte Ltd and solely to persons who qualify as an
policies and procedures; measures designed to ensure that "Institutional Investor", "Accredited Investor" or "Expert Investor"
interactions that may occur among CLSA’s Research personnel, MCI (P) 086/12/2019; in Thailand by CLSA Securities (Thailand)
Corporate Finance, Asset Management, and Sales and Trading Limited; in Taiwan by CLST and in the EU and United Kingdom by
personnel, CLSA’s financial product issuers and CLSA’s research CLSA Europe BV or CLSA (UK).
analysts do not compromise the integrity and independence of CLSA’s United States of America: Where any section is compiled by non-
research. US analyst(s), it is distributed into the United States by CLSA solely to
Subject to any applicable laws and regulations at any given time, persons who qualify as "Major US Institutional Investors" as defined
CLSA, CLST, their respective affiliates, officers, directors or in Rule 15a-6 under the Securities and Exchange Act of 1934 and who
employees may have used the information contained herein before deal with CLSA Americas. However, the delivery of this research
publication and may have positions in, or may from time to time report to any person in the United States shall not be deemed a
purchase or sell or have a material interest in any of the securities recommendation to effect any transactions in the securities discussed
mentioned or related securities, or may currently or in future have or herein or an endorsement of any opinion expressed herein. Any
have had a business or financial relationship with, or may provide or recipient of this research in the United States wishing to effect a
have provided corporate finance/capital markets and/or other transaction in any security mentioned herein should do so by
services to, the entities referred to herein, their advisors and/or any contacting CLSA Americas.
other connected parties. As a result, you should be aware that CLSA The European Union (“EU”) and the United Kingdom: In these
and/or CLST and/or their respective affiliates, officers, directors or jurisdictions, this research is a marketing communication. It has not
employees may have one or more conflicts of interest. Regulations or been prepared in accordance with the legal requirements designed to
market practice of some jurisdictions/markets prescribe certain promote the independence of investment research, and is not subject
disclosures to be made for certain actual, potential or perceived to any prohibition on dealing ahead of the dissemination of
conflicts of interests relating to research reports. Details of the investment research. The research is disseminated in these countries
disclosable interest can be found in certain reports as required by the by either CLSA (UK) or CLSA Europe BV. CLSA (UK) is authorised and
relevant rules and regulation and the full details are available at regulated by the Financial Conduct Authority. CLSA Europe BV is
http://www.clsa.com/member/research_disclosures/. Disclosures authorised and regulated by the Authority for Financial Markets in the
therein include the position of CLSA and CLST only. Unless specified Netherlands. This document is directed at persons having
otherwise, CLSA did not receive any compensation or other benefits professional experience in matters relating to investments as defined
from the subject company, covered in this in the relevant applicable local regulations. Any investment activity to
publication/communication, or from any third party. If investors have which it relates is only available to such persons. If you do not have
any difficulty accessing this website, please contact professional experience in matters relating to investments you should
[email protected] on +852 2600 8111. If you require disclosure not rely on this document. Where the research material is compiled
information on previous dates, please contact by the UK analyst(s), it is produced and disseminated by CLSA (UK)
[email protected]. and CLSA Europe BV. For the purposes of the Financial Conduct Rules
This publication/communication is distributed for and on behalf in the United Kingdom and MIFID II in other European jurisdictions
of CLSA (for research compiled by non-US and non-Taiwan analyst(s)), this research is prepared and intended as substantive research
and/or CLST (for research compiled by Taiwan analyst(s)) in Australia material.
by CLSA Australia Pty Ltd (AFSL License No: 350159); in Hong Kong For all other jurisdiction-specific disclaimers please refer to
by CLSA Limited (Incorporated in Hong Kong with limited liability); in https://www.clsa.com/disclaimer.html. The analysts/contributors to
India by CLSA India Private Limited, (Address: 8/F, Dalamal House, this publication/communication may be employed by any relevant
Nariman Point, Mumbai 400021. Tel No: +91-22-66505050. Fax No: CLSA entity or CLST, which is different from the entity that
+91-22-22840271; CIN: U67120MH1994PLC083118; SEBI distributes the publication/communication in the respective
Registration No: INZ000001735 as Stock Broker, INM000010619 as jurisdictions.© 2020 CLSA and/or CL Securities Taiwan Co., Ltd.
Merchant Banker and INH000001113 as Research Analyst,; in (“CLST”).